The Board of Pharmacy released
draft language Tuesday for proposed legislation relating to sterile injectable compounding pharmacies.
On an initial read, the main points of the legislation are the following:
- Both resident and non-resident pharmacies compounding sterile injectable products must provide the Board notice of recalls for these products within 5 days
- Non-resident pharmacies seeking to ship compounding sterile injectable products into California must provide the Board notice of either disciplinary action taken by the resident state or suspension of accreditation.
- Non-resident pharmacies seeking to ship compounding sterile injectable products into California must hold accreditation from either the Joint Commission on Accreditation of Healthcare Organizations, or some other accreditation agency approved by the Board
- Non-resident pharmacies seeking to ship compounding sterile injectable products into California must provide a copy of the self-assessment form required by section 1735.2 of Title 16.
Going forward, CSHP will be monitoring the development of this bill and advocating on behalf of California pharmacists in order to ensure patient safety and optimal use of medications.
No comments:
Post a Comment